The Ludwik Rydygier Collegium Medicum in Bydgoszcz is an extension of the Nicolaus Copernicus University in Toruń, aimed at training students in medical sciences. The Toruń University ranking among the other Polish faculties is the following: 9th according to the CWTS Leiden Ranking; 10th according to the URAP.

During the past decade, Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University" #1 sponsor was "Jan Biziel University Hospital No 2 in Bydgoszcz" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Nicolaus Copernicus University" with 1 trials sponsored, "Recardio, Inc." with 1 trials sponsored and "St. Anna Kinderkrebsforschung" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University" are "Acute Myocardial Infarction" (1 trials), "Acute Myocardial Ischemia" (1 trials), "COVID-19" (1 trials), "CRPS (Complex Regional Pain Syndromes)" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University" in a lesser frequency.

Most popular intervention types in "Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University" are "Device" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "ABI measurement" (1 trials), "Aldesleukin" (1 trials), "Amiodarone" (1 trials), "Busulfan" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".